RMTC Board Makes Therapeutic Withdrawal Recommendations, Announces Upcoming…11/15/12

NEWS RELEASE November 15, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD MAKES THERAPEUTIC WITHDRAWAL RECOMMENDATIONS, ANNOUNCES UPCOMING CORTICOSTEROIDS CONFERENCE At its November 13 meeting in Louisville, Kentucky, the Racing Medication and Testing Consortium (RMTC) board of directors addressed a number of important initiatives including therapeutic medications, laboratory proficiency, corticosteroid regulation and penalties for rule

RMTC Makes Therapeutic Withdrawal Time Recommendations, Announces Progress of its Drug… 10/20/10

NEWS RELEASE October 20, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC MAKES THERAPEUTIC WITHDRAWAL TIME RECOMMENDATIONS, ANNOUNCES PROGRESS OF ITS DRUG TESTING INITIATIVES TASK FORCE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has recommended scientifically identified withdrawal guidelines and plasma thresholds for the

RMTC Recommends New Phenylbutazone Threshold Level, Announces Launch of Recent Rulings… 4/15/10

NEWS RELEASE April 15, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC RECOMMENDS NEW PHENYLBUTAZONE THRESHOLD LEVEL, ANNOUNCES LAUNCH OF RECENT RULINGS DATABASE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has revised its recommended threshold for the non-steroidal anti-inflammatory drug (NSAID) phenylbutazone from 5

Learn About Our:

Who We Are:

Sign up to receive RMTC communications:

  • Hidden

Sign up to receive RMTC communications:

  • Hidden